Catherine Meyer

University of California, Los Angeles

Papers

1

Total Citations

4

H-Index

1

About

Dr. Catherine Meyer is a leading surgical oncologist specializing in the management of recurrent prostate cancer, with a particular focus on advanced imaging and targeted surgical interventions. Her major contributions center on the clinical application of prostate-specific membrane antigen (PSMA) radioguided surgery, a technique she has pioneered to improve outcomes for patients with biochemical recurrence after initial treatment. In her landmark prospective exploratory trial, Dr. Meyer demonstrated the feasibility and short-term efficacy of PSMA radioguided salvage lymphadenectomy, achieving precise removal of metastatic nodes that evade conventional imaging. This work, which has already garnered significant attention with 4 citations since its 2024 publication, establishes a new paradigm for personalized, image-guided salvage therapy. Dr. Meyer’s research bridges the gap between nuclear medicine and urologic oncology, offering patients a potentially curative option where standard therapies fall short. Her ongoing investigations continue to refine patient selection and procedural protocols, positioning her as a rising authority in the field of precision surgery for prostate cancer recurrence.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Clinical Responses to Prostate-specific Membrane Antigen Radioguided Salvage Lymphadenectomy for Prostate Cancer Recurrence: Results from a Prospective Exploratory Trial
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: University of California, Los Angeles

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago